FRED HUTCHINSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.fredhutch.org

Clinical Trials

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2004-04-23

Last Posted Date: 2011-06-23

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00003146

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-04-23

Last Posted Date: 2016-10-04

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00003899

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Phase 1

Completed

Conditions: Stage I Multiple Myeloma
Stage II Multiple Myeloma
Refractory Multiple Myeloma
Stage III Multiple Myeloma

Interventions: Drug: melphalan
Procedure: autologous hematopoietic stem cell transplantation
Procedure: autologous bone marrow transplantation
Procedure: peripheral blood stem cell transplantation
Radiation: total-body irradiation
Drug: cyclosporine
Drug: mycophenolate mofetil
Biological: therapeutic allogeneic lymphocytes

First Posted Date: 2004-04-15

Last Posted Date: 2020-02-06

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 40

Registration Number: NCT00003954

Locations: 🇺🇸
University of Colorado, Denver, Colorado, United States
🇺🇸
City of Hope, Duarte, California, United States
🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

and more 1 locations

Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia

Phase 2

Completed

Conditions: Leukemia

First Posted Date: 2004-04-14

Last Posted Date: 2010-04-02

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 40

Registration Number: NCT00003870

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States
🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

Phase 1

Completed

Conditions: Ovarian Cancer

First Posted Date: 2004-04-14

Last Posted Date: 2010-09-15

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00003080

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Phase 3

Completed

Conditions: Cancer

First Posted Date: 2004-04-13

Last Posted Date: 2010-04-02

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00014391

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Phase 1

Completed

Conditions: Chronic Myeloproliferative Disorders
Gestational Trophoblastic Tumor
Graft Versus Host Disease
Breast Cancer
Kidney Cancer
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Neuroblastoma

First Posted Date: 2004-04-13

Last Posted Date: 2010-04-02

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00010283

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Not Applicable

Completed

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Childhood Acute Lymphoblastic Leukemia in Remission
Adult Acute Myeloid Leukemia in Remission
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Childhood Renal Cell Carcinoma
Chronic Phase Chronic Myelogenous Leukemia
Clear Cell Renal Cell Carcinoma
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
Adult Acute Myeloid Leukemia With Del(5q)

Interventions: Drug: fludarabine phosphate
Radiation: total-body irradiation
Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
Procedure: allogeneic bone marrow transplantation
Procedure: peripheral blood stem cell transplantation
Biological: therapeutic allogeneic lymphocytes
Drug: cyclosporine
Drug: mycophenolate mofetil
Other: pharmacological study
Other: laboratory biomarker analysis

First Posted Date: 2004-04-02

Last Posted Date: 2019-09-10

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 55

Registration Number: NCT00005799

Locations: 🇩🇪
Universitaet Leipzig, Leipzig, Germany
🇺🇸
City of Hope Medical Center, Duarte, California, United States
🇺🇸
Stanford University Hospitals and Clinics, Stanford, California, United States

and more 4 locations

Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia

Phase 2

Completed

Conditions: Leukemia

First Posted Date: 2004-04-02

Last Posted Date: 2010-04-02

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00005948

Locations: 🇺🇸
University of Colorado Cancer Center, Denver, Colorado, United States
🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Phase 3

Completed

Conditions: Cancer

First Posted Date: 2004-03-31

Last Posted Date: 2010-04-02

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 578

Registration Number: NCT00003883

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Home Terms & Conditions Privacy Policy